Pramodini Medicare Ltd IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 2,532,000 | — | ₹30 Cr |
| NII (HNI) | — | 960,000 | — | ₹11 Cr |
| Retail | — | 2,023,200 | — | ₹24 Cr |
| Market Maker | — | 336,000 | — | ₹4 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹141,600 |
| Retail (Max) | 13 | 15,600 | ₹1,840,800 |
| S-HNI (Min) | 14 | 16,800 | ₹1,982,400 |
| B-HNI (Min) | 67 | 80,400 | ₹9,487,200 |
Financial Statements Amount in ₹ Crore
| Metric | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue | 63 | 39 | 36 |
| EBITDA | 31 | 21 | 16 |
| Profit After Tax | 17 | 11 | 7 |
| Net Worth | 53 | 36 | 25 |
| Total Assets | 94 | 56 | 49 |
| Reserves & Surplus | 36 | 34 | 23 |
| Total Borrowing | 18 | 11 | 12 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres – 45.15
- General corporate purposes and unidentified inorganic acquisition –
Company Overview
Incorporated in 2000, Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments. The company provides services to public hospitals, private hospitals, public sector undertakings (PSUs), medical colleges, and private diagnostic centres across tier I, II, and III cities.
Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound with colour doppler, mammography, Dexa scan, and interventional radiology; clinical laboratory services including haematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine services such as PET-CT, SPECT, and nuclear therapy. The company also operates a 24×7 teleradiology unit from Vijayawada and a processing laboratory at the same location.
Service Model
- Public-Private Partnership (PPP): Operates diagnostic centres within government hospitals and medical colleges through long-term MOUs.
- Private-Private Partnership (Pvt-Pvt): Establishes and manages diagnostic centres inside private hospitals under partnership agreements.
- Strategic Partnerships with PSUs: Collaborates with Government of India PSUs to operate diagnostic and imaging centres across multiple states.
- Standalone Diagnostic Centres: Operates its own diagnostic centres and laboratories, serving both individual patients and hospitals.
- Location-Specific Agreements: Each diagnostic centre operates under separate MOUs or contracts with terms customized for the respective location.
The business operates through four models: public-private partnership (PPP) with government hospitals and teaching institutions, private-private partnerships with hospitals, strategic partnerships with PSUs, and standalone private diagnostic centres. As of August 04, 2026, the company operated 16 diagnostic centres across seven states.
As of March 31, 2026, the company had 161permanent employees.
Competitive Strengths:
- Establishing a strategic presence across various states of India.
- Strengthening its network through diversified business models.
- Strong technical capabilities supported by robust IT infrastructure.
- Experienced management team with significant industry expertise.
- Consistent track record of revenue growth and financial performance.
- Diverse customer base, including hospitals, institutions, and individual patients.